levaquin 500 mg film-coated tablet film-coated tablet
saja-saudi arabian japanese pharmaceutical co, saudi arabia - levofloxacin - film-coated tablet - 500 mg
tavflox 500 mg film-coated tablet film-coated tablet
middle east pharmaceutical industries co ltd avalon pharma, saudi arabia - levofloxacin - film-coated tablet - 500 mg
leflox 750 mg tablets film-coated tablet
getz pharma (pvt) limited 29-30, sector 27, korangi industrial - levofloxacin - film-coated tablet - 750 mg - antibacterials for systemic use: fluoroquinolones
levin 500 film-coated tablet
hetero labs limited 7-2-a2 hetero corporate industrial estates sanath - levofloxacin hemihydrate - film-coated tablet - each film coated tablet contains512.47 mg of - antibacterials for systemic use: fluoroquinolones
levofloxacin 750mg tablets film-coated tablet
levofloxacin - film-coated tablet - levofloxacin 750mg - levofloxacin
levonic 750 mg film-coated tablet film-coated tablet
jazeera pharmaceutical industries (jpi), saudi arabia - levofloxacin - film-coated tablet - 750 mg
princeoxin 250 mg film-coated tablet film-coated tablet
apotex, canada - levofloxacin - film-coated tablet - 250 mg
evox 250mg film coated tablet
jordan sweden medical and sterilization co., jordan - levofloxacin - film-coated tablet - 250 mg
levofloxacin tablet, film coated
proficient rx lp - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin tabletsand other antibacterial drugs, levofloxacin tabletsshould be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. levofloxacin tablets are indicated for the treatment of adults (≥ 18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to levofloxacin [see micr
levofloxacin tablet, film coated
proficient rx - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin tabletsand other antibacterial drugs, levofloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. levofloxacin tablets are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to levofloxacin [see micr